Fresh Equities



Company Information

Suda Pharmaceuticals Ltd (SUD, formerly Suda Ltd) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. Administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), offers ease of use, lower dosage, reduced side effects and faster response time. SUDA operates solely in Australia. Former Names Eastland Medical Systems Ltd (EMS), 06/12/2012; Suda Ltd (SUD), 04/12/2017


Listed Company

GICS Sub-Industry


Head Office

Unit 12, Level 1/55 Howe St, Osborne Park WA 6017, Australia

Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.